DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20181198

Predictors of HPV-associated knowledge: findings from the 2017 HINTS survey

Alexander J. Mann

Abstract


Background: Over a decade since the introduction of high-efficacy HPV vaccines, a large proportion of the public lack adequate knowledge of HPV and the HPV vaccine. Continued analysis of newly available data is required to identify disparities in knowledge and target groups with low awareness.

Methods: The Health Information Trends Survey 5 cycle 1 (2017) data was analyzed. Descriptive statistics were generated, and weighted data was used to identify and quantify predictors of HPV and HPV-associated knowledge. The study population included 3,209 respondents and were mostly Caucasian (71%), female (60%), 50-59 years of age, married or previously married (81%), with some education past high school (72%).

Results: Of the 3,209 respondents, 63% had heard of HPV, 62% had heard of the vaccine, and 53% had heard of both. Women were more likely than men to have heard of HPV and the HPV vaccine. Education and income were the greatest predictors of HPV-associated knowledge. College graduates were almost five times more likely to have heard of HPV than those without high school education, whereas respondents with a household income over $100,000 were three times more likely to have HPV-associated knowledge than those under $35,000.

Conclusions: Evidence of knowledge disparities is greatest between genders, income brackets and education. These disparities highlight challenges in vaccine accessibility due to cost, and a lack of awareness in men and minority groups stemming from outdated awareness campaigns. Improvements in vaccine uptake may be achieved by targeting minority groups to increase HPV and HPV vaccine awareness, and through vaccine subsidization to maximize accessibility to those in the lowest income bracket.


Keywords


Disparities, Human papillomavirus, Vaccine, Awareness

Full Text:

PDF

References


Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, et al. CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep. 2014;63:69-72.

Taylor S, Bunge E, Bakker M, Castellsagué X. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC infectious diseases. 2016;16:293.

Viens LJ. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morbidity and mortality weekly report; 2016: 65.

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-301.

Daniel-Ulloa J, Gilbert PA, Parker EA. Human papillomavirus vaccination in the United States: uneven uptake by gender, race/ethnicity, and sexual orientation. American J Public Health. 2016;106:746-7.

Lu P-J, Yankey D, Jeyarajah J, O'Halloran A2, Elam-Evans LD2, Smith PJ, et al. HPV vaccination coverage of male adolescents in the United States. Pediatrics. 2015;136(5):839-49.

Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, et al. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. The Pediatr Infect Dis J. 2007;26:201-9.

Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:784-92.

Brotherton J, Murray SL, Hall MA, Andrewartha LK, Banks CA, Meijer D, et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust. 2013;199:614-7.

Ali H, Donovan B, Wand H, Tim RH, Regan DG, Grulich AE, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ. 2013;346:f2032.

Foley OW, Birrer N, Rauh-Hain JA, Clark RM, DiTavi E, Del Carmen MG. Effect of educational intervention on cervical cancer prevention and screening in Hispanic women. J Community Health. 2015;40:1178-84.

Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30:3546-56.

Sherman S, Nailer E, Minshall C, Coombes R, Cooper J, Redman C. Awareness and knowledge of HPV and cervical cancer in female students: A survey (with a cautionary note). J Obstetrics Gynaecol. 2016; 36: 76-80.

Blake KD, Ottenbacher AJ, Rutten LJF, Grady MA, Kobrin SC, Jacobson RM, et al. Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Prev Med. 2015;48:402-10.

Gerend MA, Shepherd MA, Lustria MLA, Shepherd JE. Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey. Sex Transm Infect. 2016;92(2):104-7.

Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine. 2016;34:1187-92.

Kontos EZ, Emmons KM, Puleo E, Viswanath K. Contribution of communication inequalities to disparities in human papillomavirus vaccine awareness and knowledge. Am J Public Health. 2012;102:1911-20.

Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168:76-82.

Davlin S, Berenson A, Rahman M. Correlates of HPV knowledge among low-income minority mothers with a child 9-17 years of age. J Pediatric Adolescent Gynecol. 2015;28:19-23.

Wisk LE, Allchin A and Witt WP. Disparities in human papillomavirus vaccine awareness among US parents of preadolescents and adolescents. Sexually transmitted diseases. 2014;41:117.

Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD. Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect. 2014;90:515-23.

Reimer RA, Schommer JA, Houlihan AE, Gerrard M. Ethnic and gender differences in HPV knowledge, awareness, and vaccine acceptability among White and Hispanic men and women. Journal of community health. 2014;39:274-84.

Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813-9.